Zagociguat

N/A

Report date: 2026/02/07 20:00:33
NME

Base Information

Drug NameZagociguat
Drug Alias NameIW-6463CY-6463
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsOthersAlzheimer DiseaseMELAS Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMELAS Syndrome
Inactive IndicationsOthersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A